Arnica, MSM and Boswellia: what the evidence actually says

Why these three keep appearing

Pick up any botanical joint gel and you will likely see arnica, MSM and Boswellia. That is not coincidence or copying — they cover three different jobs: bruising and soreness, connective tissue support, and inflammation itself.

The interesting question is not whether they are 'natural' but how much evidence each carries, and how honest the labels are about it.

Arnica montana

Arnica is the oldest of the three in Western use, traditionally for bruising and muscle soreness. Topical arnica gel has been compared with ibuprofen gel in hand osteoarthritis and performed comparably in at least one reasonably designed trial.

The evidence is far better for topical preparations at real concentrations than for homeopathic dilutions, which are pharmacologically negligible. If a product lists arnica as an extract rather than a 30C dilution, it is at least in the territory where an effect is plausible.

Verdict: modest but real support for soreness and bruising. Not a serious anti-inflammatory on its own.

MSM (methylsulfonylmethane)

MSM is a small sulphur-containing molecule, and sulphur is a building block of the connective tissue matrix. Its small size is also why it appears in topicals: it crosses skin more easily than bulkier botanicals.

Most of the human trial data is on oral MSM in knee osteoarthritis, where several small randomised studies found improvements in pain and function versus placebo. The trials are small and the effect sizes are moderate, but they are consistent in direction.

Topical MSM has much thinner direct evidence. The reasonable position is that it is a well-chosen ingredient with mechanistic logic and decent oral data, not a proven topical.

Verdict: the best-supported of the three for joints overall, weakest specifically as a topical.

Boswellia serrata

Boswellia — frankincense — contains boswellic acids that inhibit 5-lipoxygenase, an enzyme in a genuine inflammatory pathway. That is a specific, describable mechanism rather than a vague claim.

Meta-analyses of oral Boswellia extracts in knee osteoarthritis have found reductions in pain and stiffness compared with placebo, with the caveat that many trials are small and industry-funded. Standardised extracts perform better than unspecified powders.

Verdict: the most mechanistically credible anti-inflammatory of the three, with supportive oral evidence and limited topical evidence.

The honest summary

Combined, these three cover soreness, tissue support and inflammation with a plausible logic. None of them, individually or together, has the trial weight of topical diclofenac. Anyone claiming otherwise is overselling.

What they offer instead is a route for people who cannot or will not use NSAIDs long term — and for that group the comparison that matters is against doing nothing, not against a drug they cannot take.

How to read a label properly

Look for named, standardised extracts rather than a vague 'herbal blend'. Look for the ingredient's position in the list, which reflects relative quantity. Look at the carrier, because a good active in a poor base goes nowhere.

And treat any product promising cartilage regeneration or a cure as disqualified, regardless of how good the actives look.